Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);结直肠肿瘤(Colorectal Neoplasms);外显子(Exons);女(雌)性(Female);GTP磷酸水解酶类(GTP Phosphohydrolases);人类(Humans);男(雄)性(Male);膜蛋白质类(Membrane Proteins);中年人(Middle Aged);突变(Mutation);预后(Prognosis);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));随机对照试验(主题)(Randomized Controlled Trials as Topic);回顾性研究(Retrospective Studies)
DOI
10.1016/j.clcc.2018.03.005
PMID
29627309
发布时间
2019-04-22
- 浏览5

Clinical colorectal cancer
170-178.e3页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文